Andrew Sharff
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
Papers in
-
- Protein Structure and Dynamics 8
- Biochemical and Molecular Research 4
-
- Enzyme Structure and Function 12
- Co-authors
- G. Bricogne (12 shared papers)Claus Flensburg (5 shared papers)Clemens Vonrhein (5 shared papers)W. A. Paciorek (4 shared papers)Ben F. Luisi (5 shared papers)Peter M. Keller (2 shared papers)Thomas Womack (2 shared papers)Oliver S. Smart (2 shared papers)
- Journals
- Journal of Molecular Biology (4 papers)Biochemistry (3 papers)Protein Science (2 papers)Acta Crystallographica Section A Foundations and Advances (2 papers)Drug Discovery Today Technologies (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Andrew Sharff
30 papers receiving 4.4k citations
Andrew Sharff's Hit Papers
Peers
Comparison fields: 5 of 129
- Molecular Medicine 514
- Endocrinology 271
- Molecular Biology 2.7k
- Genetics 800
- Infectious Diseases 504
Countries citing papers authored by Andrew Sharff
This map shows the geographic impact of Andrew Sharff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Sharff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Sharff more than expected).
Fields of papers citing papers by Andrew Sharff
This network shows the impact of papers produced by Andrew Sharff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Sharff. The network helps show where Andrew Sharff may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Sharff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Data processing and analysis with theautoPROCtoolbox Hit paper breakdown → | 2011 | 1348 |
| 2 | Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export Hit paper breakdown → | 2000 | 920 |
| 3 | 2012 | 459 | |
| 4 | 1992 | 433 | |
| 5 | 2011 | 270 | |
| 6 | 1993 | 162 | |
| 7 | 2018 | 87 | |
| 8 | 2001 | 87 | |
| 9 | 2007 | 75 | |
| 10 | 2010 | 71 | |
| 11 | 2006 | 67 | |
| 12 | 2003 | 60 | |
| 13 | 1992 | 56 | |
| 14 | 2004 | 54 | |
| 15 | 2014 | 54 | |
| 16 | 2001 | 44 | |
| 17 | 2018 | 39 | |
| 18 | 2011 | 33 | |
| 19 | 2001 | 27 | |
| 20 | 2011 | 25 |
About Andrew Sharff
Andrew Sharff is a scholar working on Molecular Biology, Materials Chemistry, Genetics, Computational Theory and Mathematics and Cell Biology, having authored 31 papers that have together received 4.5k indexed citations. Recurring topics across this work include Enzyme Structure and Function (12 papers), Protein Structure and Dynamics (8 papers), Biochemical and Molecular Research (4 papers), Bacterial Genetics and Biotechnology (4 papers), Computational Drug Discovery Methods (3 papers), Neurofibromatosis and Schwannoma Cases (2 papers), Organic Chemistry Cycloaddition Reactions (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Molecular Medicine (514 citations), Endocrinology (271 citations), Molecular Biology (2.7k citations), Genetics (800 citations) and Infectious Diseases (504 citations). Andrew Sharff has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include G. Bricogne, Claus Flensburg, Clemens Vonrhein, W. A. Paciorek, Ben F. Luisi, Peter M. Keller, Thomas Womack, Oliver S. Smart, Eva Koronakis and Vassilis Koronakis. Their work appears in journals such as Journal of Molecular Biology, Biochemistry, Protein Science, Acta Crystallographica Section A Foundations and Advances and Drug Discovery Today Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.